Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Pelthos Therapeutics Inc. (NASDAQ: PTHS) Director Peter Greenleaf executed a series of stock sales totaling $20,826 on July 2, 2026. The transactions, facilitated through a Rule 10b5-1 plan established in December 2025, were designated to cover tax liabilities associated with vesting restricted stock units. Following the divestment, Greenleaf retai…
Imunon Inc. (NASDAQ: IMNN) reported a recent equity transaction involving its General Counsel and Corporate Secretary, Susan Eylward. The filing details a sale of company stock shortly after an equity-based compensation grant, occurring against a backdrop of significant earnings misses and ongoing clinical trial financing. This activity highlights …
James R. Potts, Executive Vice President and General Counsel at Barrett Business Services Inc. (NASDAQ: BBSI), executed a series of stock sales totaling $332,021 in early July 2026. The transactions, conducted under a pre-arranged Rule 10b5-1 trading plan, reduce his direct holdings to 32,035 shares. The insider activity occurs as BBSI navigates a …
John J. Fitzgerald, a director at WidePoint Corp (NASDAQ:WYY), executed a significant divestment of company shares totaling $234,450 on July 6, 2026, according to a recent filing with the Securities and Exchange Commission. This transaction, involving the sale of 15,000 shares at a weighted average price of $15.63 per share, takes place against a b…
Robert Enslin, President and Chief Commercial Officer of Workday, Inc., executed two separate transactions on July 5, 2026, resulting in the sale of 11,008 shares of Class A Common Stock. The first sale, conducted under a Rule 10b5-1 trading plan, netted $724,971, while the second represented tax withholding on restricted stock unit vesting valued …
David A. Duffield, a prominent shareholder and founder of Workday, Inc. (NASDAQ:WDAY), executed a sale of Class A Common Stock valued at approximately $14.5 million on July 6, 2026. The transaction involved 107,500 shares sold at prices between $129.23 and $139.2999 per share. These sales were carried out under a Rule 10b5-1 trading plan, which fac…
Corebridge Financial CIO David Ditillo sold 4,250 shares on July 6, 2026, at $30.00 per share, totaling $127,500. The transaction was reported on July 7, 2026, via a Form 4 filing with the SEC. Post-transaction, Ditillo holds 128,153 shares, including 40,342 restricted stock units. Corebridge Financial's stock has risen to $30.60, reflecting a 7.6%…
Dolphin Entertainment, Inc. (NASDAQ:DLPN) Chief Executive Officer William O’Dowd IV recently executed a stock purchase totaling $4,983, acquiring 4,300 shares on July 6, 2026. This transaction occurs against a backdrop of a 26% year-to-date decline in the stock's price and recent financial reports showing revenue growth alongside persistent operati…
Martin C Bicknell, recognized as a ten percent owner of Palmer Square Capital BDC Inc., has executed a series of purchases totaling approximately $647,337 in the company's common stock. The transactions occurred on July 6 and July 7, 2026, and were facilitated indirectly through MCHC, LLC. This acquisition activity takes place against a backdrop of…
Kevin J. Knopp, President and CEO of 908 Devices Inc. (NASDAQ:MASS), executed a sale of company stock totaling $2,013 on July 2, 2026. The transaction involved 222 shares sold at prices between $9.062 and $9.07 per share under a Rule 10b5-1 trading plan adopted in May 2025. This sale occurs as the stock has experienced significant gains, trading ne…
Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), executed a series of stock sales totaling approximately $139,849 on July 6, 2026. The transaction involved the liquidation of 6,000 shares of common stock, which were sold following the exercise of fully vested stock options. This insider activity occurs agains…
Anthony Meeker, a director at Barrett Business Services Inc. (NASDAQ:BBSI), executed a sale of 12,000 shares on July 2, 2026, totaling approximately $454,226. The transaction occurred as the company navigates reported macroeconomic challenges and recent financial disclosures. Meeker retains a direct stake of 44,945 shares following the divestment. …
Jennifer Fitzpatrick, Sionna Therapeutics' Chief Legal Officer, executed a sale of 10,250 shares on July 6, 2026, utilizing a Rule 10b5-1 trading plan established in June 2025. The transaction, valued at $446,862, occurred while the company's stock trades near its 52-week high, amid a period of heightened analyst scrutiny regarding its cystic fibro…
HRT Financial LP, a significant ten percent stakeholder in Edible Garden AG Inc. (NASDAQ: EDBL), has expanded its direct ownership through a series of strategic acquisitions totaling $63,435. These purchases, executed in early July 2026, occurred while the stock was trading near its 52-week low of $0.10, following a notable 39% decline over the pre…
Michael Henry Fiore, Executive Vice President and Chief Commercial Officer at HealthEquity, Inc. (NASDAQ: HQY), has executed a sale of 2,470 shares of the company’s common stock. The transaction, valued at $234,650, was conducted at a price of $95.0 per share on July 2, 2026. This sale was carried out under a Rule 10b5-1 trading plan established by…
Jenny C. Yeh, Senior Vice President and Chief Legal Officer at Ooma Inc. (NASDAQ: OOMA), executed a sale of 12,840 shares on July 1, 2026, totaling approximately $251,298. The transaction occurred as Ooma's stock trades near its 52-week high of $21.96, following a significant 70% price increase over the previous six months. The sale was reported vi…
Datadog, Inc. (NASDAQ: DDOG) Director Amit Agarwal executed a significant divestment of 19,900 Class A Common Stock shares on July 2, 2026, realizing approximately $5.22 million in proceeds. The transaction was facilitated through the Agarwal 2018 Family Trust and adhered to a pre-arranged 10b5-1 trading plan established on March 13, 2026. This sal…
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) director Rogerio Vivaldi Coelho sold 3,000 shares of the company's common stock on July 2, 2026, in a transaction valued at $120,000. The shares were sold at $40.00 each and were executed through open market transactions under a Rule 10b5-1 trading plan adopted on December 11, 2025. Following the sale, …
Yvonne Hui, Principal Accounting Officer at Phreesia, Inc. (NASDAQ:PHR), executed a sale of 1,371 shares of the company's common stock on July 6, 2026, totaling $14,861. The transaction, priced at $10.84 per share, was conducted under a Rule 10b5-1 trading plan established on January 15, 2026. Post-transaction, Hui retains direct ownership of 23,90…
Andrew Dakos, President and CEO of Total Return Securities Fund, has increased his ownership stake following a recent share acquisition. The transaction occurred as the stock traded near its 52-week low, with the fund maintaining profitability and a low price-to-earnings ratio. This insider activity provides insight into executive sentiment regardi…
HRT Financial LP, a notable ten percent shareholder in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), executed recent transactions involving the company's common stock. The firm sold 9,022 shares on July 6, 2026, at $3.51 per share, while previously acquiring 7,851 shares on July 2, 2026, at $3.54 per share. These activities follow Shuttle P…
Rudy Mitchell Austin, a director and significant 10% shareholder of BONK, INC. (NASDAQ:BNKK), has increased his indirect ownership in the company. The acquisition, executed through Nom Capital ULC, brings his total holdings to 85,000 shares. This move occurs against a backdrop of significant stock price depreciation over the past year and recent re…
Jill Foss Watson, a principal 10% owner of Credit Acceptance Corp (NASDAQ:CACC), executed a significant sale of 11,100 shares on July 2, 2026. The transactions, valued at approximately $7.19 million, occurred as the stock trades near its 52-week peak. The sale was facilitated through two distinct trust structures, leaving Watson with substantial in…
Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc., executed a series of transactions involving the company’s Class A Common Stock on July 6, 2026. The CFO exercised stock options and subsequently sold 7,163 shares through a Rule 10b5-1 trading plan established on May 21, 2025. The sale, valued at approximately $261,351, occurred at…
Aidan Viggiano, Chief Financial Officer at Twilio Inc. (NASDAQ: TWLO), sold 8,528 shares of the company’s Class A common stock for $1,751,907 on July 2, 2026, according to a filing with the Securities and Exchange Commission. The sale was conducted under a pre-arranged 10b5-1 trading plan established on June 6, 2025. Following the transaction, Vigg…
